MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial
International Journal of Clinical Oncology · 2024
DOI: 10.1007/s10147-024-02490-7 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Han Byul Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy, Magnetic Resonance Imaging, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This subgroup analysis of a prospective phase II trial aimed to identify valuable and accessible prognostic factors for overall survival (OS) and progression-free survival (PFS) of patients with locally advanced cervical cancer (LACC). METHODS: Patients with FIGO II to IVA cervical cancer were assessed in this study. All patients underwent concurrent chemoradiotherapy (CCRT) followed by brachytherapy. Tumor parameters based on MRI scans before and during CCRT were evaluated for Overall survival (OS) and Progression-free survival (PFS). RESULTS: A total of 86 patients were included in this analysis with a median follow-up period of 31.7 months. Three-year OS and PFS rates for all patients were 87.1% and 76.5%, respectively. Univariate Cox regression analysis showed that restaging tumor size (rTS) over 2.55 cm (p 2.55 cm showed statistically significant with OS (HR: 5.47, 95% CI 1.80-9.58, p = 0.035) and PFS (HR: 3.83, 95% CI 1.50-11.45; p = 0.025). CONCLUSIONS: Initial tumor size and restaging tumor volume that are easily accessible during radiotherapy provide valuable prognostic information for cervical cancer. MRI-based measurable volumetric scoring system can be readily applied in real-world practice of cervical cancer. CLINICAL TRIAL INFORMATION: This study is a subgroup analysis of prospective trial registered at ClinicalTrials.gov Identifier: NCT02993653.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
- Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. koppul@catholic.ac.kr.
Zitieren
APA
Kang, H. B., Kim, S. H., Lee, J. H., Lee, H. C., Kang, N. K., & Lee, J. H. (2024). MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02490-7
Vancouver
Kang HB, Kim SH, Lee JH, Lee HC, Kang NK, Lee JH. MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02490-7
BibTeX
@article{Kang2024,
author = {Kang, Han Byul and Kim, Sung Hwan and Lee, Joo Hwan and Lee, Hyo Chun and Kang, Nam Kyu and Lee, Jong Hoon},
title = {MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial},
journal = {International Journal of Clinical Oncology},
year = {2024},
doi = {10.1007/s10147-024-02490-7}
}
EUVIMED